A Randomized, Double Blind, Phase III Study to Evaluate Adjuvant cG250 Treatment versus Placebo in Patients with Clear Cell
Renal Cell Carcinoma (RCC)
Investigator: Scherr, Douglas S
Phone Number: x6-5788
A Prospective Evaluation of the Greenlight HPS Laser System and the Guided Delivery Device ("GDD") for the treatment of Benign
Prostatic ...
Investigator: Te, Alexis E
Phone Number: X6-4811
A pilot study to measure the efficacy of long-acting tolterodine on continued detrussor overactivity...
Investigator: Te, Alexis E
Phone Number: X6-4811
Prospective, Observational Registry and Patient Survey of the Management of Men with Symptomatic Benign Prostatic Hyperplasia
(BPH): BPH Registry...
Investigator: Te, Alexis E
Phone Number: X6-4811
